Summary
The content of cardiac glycosides in plasma and several organs of rats and mice was investigated 30 min and 12 hrs after i.p. administration of 160 μg/kg b.w. 3H-digitoxin. In rat plasma a glycoside concentration of 124.8 and 44.7 ng/ml resp. was found. The corresponding values in the liver were 834.7 and 579.7 ng/g w.w. An opposite liver/plasma distribution was obtained in mice: while in plasma 772.5 and 571.8 ng/ml were recovered, the glycoside concentration in liver was relatively small (284.8 and 235.6 ng/g w.w.).
In order to find out the reason for such species differences observed in vivo, liver slices of rats and mice were incubated with 3H-digitoxin in a medium with and without various plasma proteins. The uptake of 3H-digitoxin into liver slices was drastically reduced by adding mouse plasma or albumin to the medium, while rat plasma lowered the uptake far less. These differences are well reflected by binding studies on agargel electrophoresis: only in mouse plasma a binding of 3H-digitoxin could be demonstrated.
The binding rate and binding constant analyzed by equilibrium dialysis were higher in mouse than in rat plasma. It is concluded that the lower tissue accumulation in mice compared to rats must be due to the affinity of 3H-digitoxin to mouse plasma albumin. Moreover digitoxin has a higher affinity to the rat than to the mouse liver in the presence of mouse or rat plasma as well as of bovine serum albumin.
Similar content being viewed by others
References
Aebi, H.: Einführung in die praktische Biochemie, p. 204. Frankfurt: Akad. Verlagsges. 1965
Baggot, J. D., Davis, L. E.: Plasma protein binding of digitoxin and digitoxin in several mammalian species. Res. Vet. Sci. 15, 81–87 (1973)
Beeck, R., Braun, W., Damm, K. H., Erttmann, R., Gerhardt, T.: Über den Einfluß verschiedener Pharmaka auf die Eiweißbildung von Phenolrot und Digitoxin. Naunyn-Schmiedeberg's Arch. Pharmacol. 275, 277–287 (1972)
Bine, R., Friedman, M., Byers, S. O., Bland, D.: The deposition of digitoxin in the tissue of the rat after parenteral injection. Circulation 4, 105–107 (1951)
Brodie, B. B., Hogben, A. M.: Some physico-chemical factors in drug action. J. Pharm. Pharmacol. 9, 345–380 (1957)
Brown, B. T., Shepheard, E. E., Wright, S. E.: The distribution of digitalis glycosides and their metabolites within the body of the rat. J. Pharmacol. exp. Ther. 118, 39–45 (1956)
Buck, S. H., Lage, G. L.: Possible mechanisms of the prevention of digitoxin toxicity by spironolactone in the mouse. Arch. int. Pharmacodyn. 189, 192–197 (1971)
Castle, M. C., Lage, G. L.: Effect of pretreatment with spironolactone, phenobarbital or β-diethylaminoethyldiphenylpropyl (SKF 525 A) on tritium levels in blood, heart, and liver of rats at various times after administration of 3H-digitoxin. Biochem. Pharmacol. 21, 1449–1455 (1972)
Castle, M. C., Lage, G. L.: Metabolism and distribution of digitoxin in the rat. Arch. int. Pharmacodyn. 203, 323–334 (1973)
Chen, R. F.: Fluorescence spectra of human serum albumin in pH region of N-F transition. Biochim. biophys. Acta (Amst.) 120, 169–171 (1966)
Damm, K. H., Braun, W., Heckert, H.: Die Wirkung von Probenecid auf die Verteilung von Digitoxin, Digoxin und Ouabain an der Maus. Naunyn-Schmiedeberg's Arch. Pharmacol. 277, 267–279 (1973)
Damm, K. H., Erttmann, R. R.: Interaction of probenecid with digitoxin metabolism in rats. Toxicol. appl. Pharmacol. 33, 246–257 (1975)
Daughaday, W. H.: Binding of corticosteroids by plasma proteins. VI. The electrophoretic demonstration of corticosteroid binding globulin. J. clin. Invest. 37, 519–523 (1958)
Daughaday, W. H., Adler, R. E., Mariz, B. J., Rasinski, D. C.: Measurement of the binding capacity of corticosteroid-binding globulin in human plasma. J. clin. Endocr. 22, 704–710 (1962)
Farah, A.: On the combination of some cardio-active glycosides with serum proteins. J. Pharmacol. exp. Ther. 83, 143–157 (1945)
Fischer, C. S., Sjoerdma, A. S., Johnson, R.: The tissue distribution and excretion of radioactive digitoxin. Studies on normal rats and cats and rats with dietary-induced myocardial lesions. Circulation 5, 496–503 (1952)
Friedman, M., St. George, S., Bine, R., Byers, S. O., Bland, C.: Deposition and disappearence of digitoxin from the tissue of the rat, rabbit, and dog after parenteral injection. Circulation 6, 367–370 (1952)
Gadke, J., van Zwieten, P. A.: Vergleichende Untersuchungen am Meerschweinchen über die Serumradioaktivität, die Ausscheidung und die Gewebsverteilung von 3H-Digitoxin und 3H-Digitoxigenin. Naunyn-Schmiedeberg's Arch. Pharmak. 264, 234–235 (1969)
Goldstein, A.: The interaction of drugs and plasma proteins. Pharmacol. Rev. 1, 102–165 (1949)
Goldstein, A., Aronow, L., Kalman, S. M.: In: Principles of drug action, pp. 34–40. London: Harper and Row 1968
Klotz, J. M.: The application of the law of mass action to the binding by proteins with calcium. Arch. Biochem. Biophys. 9, 109–117 (1946)
Kohn, J.: Zur Technik der Zellulose-Acetat-Elektrophorese. Ärztl. Lab. 10, 269–278 (1964)
Krieg, M., Horst, H. J., Sterba, M. L.: Binding and metabolism of 5α-androstane-3α,17β-diol and 5α-androstane-3β,17β-diol in the prostate, seminal vesicles and plasma of male rats: Studies in vivo and in vitro. J. Endocr. 64, 529–538 (1975)
Krieglstein, J.: Zur Plasmaproteinbindung von Arzneimitteln. Klin. Wschr. 47, 1125–1130 (1969)
Kurz, H., Friemel, G.: Artspezifische Unterschiede der Bindung an Plasmaproteine. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 257, 35–36 (1967)
Kuschinsky, K.: Über die Bindungseigenschaften von Plasmaproteinen für Herzglykoside. Naunyn-Schmiedebergs Arch. Pharmak. exp. Pathol. 262, 388–398 (1969)
Kuschinsky, K.: The specifity of the binding of some cardenolides to human serum albumin. Arzneimittel-Forsch. 20, 842–845 (1970)
Lukas, D. S.: Some aspects of the distribution and deposition of digitoxin in man. N. Y. Acad. Sci. 179, 338–361 (1971)
Lukas, D. S.: Binding of digitoxin, digoxin, their genins and related digitoxosides to human plasma proteins. In: Digitalis, pp. 31–48. O. Storstein, ed. Oslo: Glydendahl Norsk Forlag 1973
Lukas, D. S., De Martino, A. G.: Binding of digitoxin and some related cardenolides to human plasma proteins. J. clin. Invest. 48, 1041–1053 (1969)
Lukas, D. S., Peterson, R. E.: Double isotope dilution derivative assay of digitoxin in plasma, urine, stool of patients maintained on the drug. J. clin. Invest. 45, 782–795 (1966)
Okita, G. T.: Distribution, deposition and excretion of digitalis glycosides. In: Digitalis. C. Fisch and B. Surawicz, pp. 13–27. New York-London: Greene and Strattau 1974
Oriol-Bosch, A., Voigt, K. D.: Über die Anwendung einer Cellulose-Acetat-Folie für die Eiweißelektrophorese. Klin. Wschr. 37, 758–761 (1959)
Repke, K.: Über Verteilung, Ausscheidung und Stoffwechsel von Digitoxin bei der Ratte. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 233, 271–283 (1958c)
Russell, J. Q., Klaassen, C. D.: Biliary excretion of cardiac glycosides. J. Pharmacol. exp. Ther. 186, 455–462 (1973)
Scatchard, G.: The attractions of protein for small molecules and ions. Ann. N. Y. Acad. Sci. 51, 660 (1949)
Scholtan, W.: Die Bindung der Langzeitsulfonamide an die Eiweißkörper des Serums. Arzneimittel-Forsch. 11, 707–720 (1961)
Scholtan, W., Schlossmann, K., Rosenkranz, H.: Bestimmung der Eiweißbindung von Digitalispräparaten mittels Ultrazentrifuge. Arzneimittel-Forsch. 16, 109–118 (1966)
Spratt, J. L., Okita, G. T.: Protein binding of radioactive digitoxin. J. Pharmacol. exp. Ther. 124, 109–114 (1958)
Wagner, R. K.: Characterization and assay of steroid hormone receptors and steroid binding serum proteins by agargel electrophoresis at low temperature. Hoppe-Seylers Z. physiol. Chem. 353, 1235–1245 (1972)
Westphal, U.: Steroid-protein interactions. XIII. Concentration and binding affinities of corticosteroid-binding-globulin in sera of man, monkey, rat, rabbit and guinea pig. Arch. Biochem. 118, 556–567 (1967)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Damm, K.H., Erttmann, R.R., Hoene, R. et al. Species differences in plasma binding and tissue uptake of 3H-digitoxin. Naunyn-Schmiedeberg's Arch. Pharmacol. 291, 371–383 (1975). https://doi.org/10.1007/BF00501795
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00501795